Published in Stem Cells Dev on March 18, 2015
Radio-resistant mesenchymal stem cells: mechanisms of resistance and potential implications for the clinic. Oncotarget (2015) 0.82
Patient-Specific Age: The Other Side of the Coin in Advanced Mesenchymal Stem Cell Therapy. Front Physiol (2015) 0.77
Immunomodulatory oligonucleotide IMT504: Effects on mesenchymal stem cells as a first-in-class immunoprotective/immunoregenerative therapy. World J Stem Cells (2017) 0.75
Experimental study of vein subvolution combined with neural stem cells to repair sciatic neurologic defects in rats. Int J Clin Exp Pathol (2015) 0.75
Human umbilical cord blood-borne fibroblasts contain marrow niche precursors that form a bone/marrow organoid in vivo. Development (2017) 0.75
Fat-Derived Stromal Vascular Fraction Cells Enhance the Bone-Forming Capacity of Devitalized Engineered Hypertrophic Cartilage Matrix. Stem Cells Transl Med (2016) 0.75
Succinate promotes stem cell migration through the GPR91-dependent regulation of DRP1-mediated mitochondrial fission. Sci Rep (2017) 0.75
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy (2006) 37.55
The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. Nat Med (2013) 4.32
Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med (2001) 3.73
Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal (2011) 3.31
CCL2 and interleukin-6 promote survival of human CD11b+ peripheral blood mononuclear cells and induce M2-type macrophage polarization. J Biol Chem (2009) 2.81
Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells (2005) 2.53
Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells (2007) 2.46
Immune properties of human umbilical cord Wharton's jelly-derived cells. Stem Cells (2008) 2.19
Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow. Endocrinology (1997) 1.96
Wound macrophages as key regulators of repair: origin, phenotype, and function. Am J Pathol (2010) 1.83
Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially. PLoS One (2010) 1.64
Kinetic analysis and modeling of firefly luciferase as a quantitative reporter gene in live mammalian cells. Biotechnol Bioeng (2004) 1.59
Evaluation of bone regeneration using the rat critical size calvarial defect. Nat Protoc (2012) 1.51
Role of adult mesenchymal stem cells in bone tissue engineering applications: current status and future prospects. Tissue Eng (2005) 1.50
Mesenchymal stem cells from human umbilical cord express preferentially secreted factors related to neuroprotection, neurogenesis, and angiogenesis. PLoS One (2013) 1.47
Human Wharton's jelly stem cells have unique transcriptome profiles compared to human embryonic stem cells and other mesenchymal stem cells. Stem Cell Rev (2011) 1.45
Osteoblastic differentiation of Wharton jelly biopsy specimens and their mesenchymal stromal cells after serum-free culture. Plast Reconstr Surg (2014) 1.43
The osteogenic differentiation of adult bone marrow and perinatal umbilical mesenchymal stem cells and matrix remodelling in three-dimensional collagen scaffolds. Biomaterials (2009) 1.40
Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells. Cell Transplant (2010) 1.36
Growth and differentiation properties of mesenchymal stromal cell populations derived from whole human umbilical cord. Stem Cell Rev (2011) 1.35
Osteoblastic differentiation of human mesenchymal stem cells with platelet lysate. Biomaterials (2009) 1.32
Immunosuppressive properties of human umbilical cord-derived mesenchymal stem cells: role of B7-H1 and IDO. Immunol Cell Biol (2010) 1.29
Immune response to fetal calf serum by two adenosine deaminase-deficient patients after T cell gene therapy. Hum Gene Ther (2002) 1.27
Identification of subpopulations in mesenchymal stem cell-like cultures from human umbilical cord. Cell Commun Signal (2009) 1.23
Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical study. Arthritis Res Ther (2014) 1.22
Functional module analysis reveals differential osteogenic and stemness potentials in human mesenchymal stem cells from bone marrow and Wharton's jelly of umbilical cord. Stem Cells Dev (2010) 1.21
Human platelet lysate allows expansion and clinical grade production of mesenchymal stromal cells from small samples of bone marrow aspirates or marrow filter washouts. Bone Marrow Transplant (2007) 1.19
Umbilical cord-derived mesenchymal stem cells: Their advantages and potential clinical utility. World J Stem Cells (2014) 1.16
Mesenchymal stem cells and Interleukin-6 attenuate liver fibrosis in mice. J Transl Med (2013) 1.14
In vitro and in vivo evaluation of a novel nanosize hydroxyapatite particles/poly(ester-urethane) composite scaffold for bone tissue engineering. Acta Biomater (2009) 1.11
Angiogenesis is not impaired in connective tissue growth factor (CTGF) knock-out mice. J Histochem Cytochem (2007) 1.10
Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells. Stem Cell Res Ther (2013) 1.07
Distinct differentiation potential of "MSC" derived from cord blood and umbilical cord: are cord-derived cells true mesenchymal stromal cells? Stem Cells Dev (2012) 1.07
Protein synthesis and secretion in human mesenchymal cells derived from bone marrow, adipose tissue and Wharton's jelly. Stem Cell Res Ther (2014) 1.05
Human Wharton's Jelly Mesenchymal Stem Cells plasticity augments scar-free skin wound healing with hair growth. PLoS One (2014) 1.04
Minimally manipulated whole human umbilical cord is a rich source of clinical-grade human mesenchymal stromal cells expanded in human platelet lysate. Cytotherapy (2011) 1.03
Treatment of graft versus host disease with mesenchymal stromal cells: a phase I study on 40 adult and pediatric patients. Biol Blood Marrow Transplant (2013) 1.02
A nude mouse model for human bone formation in unloaded conditions. Bone (1998) 1.00
Mesenchymal stromal cells of human umbilical cord Wharton's jelly accelerate wound healing by paracrine mechanisms. Cytotherapy (2012) 0.95
Umbilical cord mesenchymal stem cells: the new gold standard for mesenchymal stem cell-based therapies? Tissue Eng Part B Rev (2014) 0.94
The role of bFGF on the ability of MSC to activate endogenous regenerative mechanisms in an ectopic bone formation model. Biomaterials (2011) 0.93
Unique molecular signatures influencing the biological function and fate of post-natal stem cells isolated from different sources. J Tissue Eng Regen Med (2012) 0.92
Regeneration of large bone defects in sheep using bone marrow stromal cells. J Tissue Eng Regen Med (2008) 0.91
Effectiveness of protocol for the isolation of Wharton's Jelly stem cells in large-scale applications. In Vitro Cell Dev Biol Anim (2009) 0.90
Mesenchymal stem cells and bioceramics: strategies to regenerate the skeleton. Novartis Found Symp (2003) 0.89
Short-time survival and engraftment of bone marrow stromal cells in an ectopic model of bone regeneration. Tissue Eng Part A (2010) 0.88
A platelet-rich plasma-based membrane as a periosteal substitute with enhanced osteogenic and angiogenic properties: a new concept for bone repair. Tissue Eng Part A (2012) 0.88
Comparison of chemokine and receptor gene expression between Wharton's jelly and bone marrow-derived mesenchymal stromal cells. Cytotherapy (2011) 0.87
Functional analysis reveals angiogenic potential of human mesenchymal stem cells from Wharton's jelly in dermal regeneration. Angiogenesis (2014) 0.87
Mesenchymal stem cells support proliferation and terminal differentiation of B cells. Cell Physiol Biochem (2012) 0.85
Cotransplantation of haploidentical hematopoietic and umbilical cord mesenchymal stem cells for severe aplastic anemia: successful engraftment and mild GVHD. Stem Cell Res (2013) 0.85
Enhanced engraftment of EPO-transduced human bone marrow stromal cells transplanted in a 3D matrix in non-conditioned NOD/SCID mice. Gene Ther (2002) 0.84
Umbilical cord mesenchymal stem cells suppress B-cell proliferation and differentiation. Cell Immunol (2012) 0.83
Opinion of the EMEA on the potential risk associated with medicinal products in relation to bovine spongiform encephalopathy (BSE) (16 April 1996) and report from the Committee for Proprietary Medicinal Products (CPMP) on the 'Note for Guidance on minimizing the risk of transmitting animal spongiform encephalopathies via medicinal products' (15 April 1997). Adverse Drug React Toxicol Rev (1997) 0.83
PGE/cAMP and GM-CSF synergise to induce a pro-tolerance cytokine profile in monocytic cell lines. Biochem Biophys Res Commun (2005) 0.83
Recruitment of host's progenitor cells to sites of human amniotic fluid stem cells implantation. Biomaterials (2011) 0.82
Efficient expansion of mesenchymal stromal cells from umbilical cord under low serum conditions. Cytotherapy (2009) 0.81
Capability of human mesenchymal cells isolated from different sources to differentiation into tissues of mesodermal origin. Bull Exp Biol Med (2007) 0.81
The Regenerative Role of the Fetal and Adult Stem Cell Secretome. J Clin Med (2013) 0.79